How should we assess very uncertain and non-testable stuff?

There is a good and widely accepted approach to assessing testable projects - roughly what GiveWell does.  It is much less clear how EA research organisations should assess projects, interventions and organisations with very uncertain non-testable impact, such as policy work or academic research. There are some disparate materials on... Read More

High Time For Drug Policy Reform. Part 4/4: Estimating Cost-Effectiveness vs Other Causes; What EA Should Do Next

This is the fourth of four posts on DPR. In this part I provide some simplistic but illustrative cost-effectiveness estimates comparing an imaginary campaign for DPR against current interventions for poverty, physical health and mental health; I also consider what EAs should do next. Links to the articles in this series: Part... Read More

Local Group Support Overview: CEA, EAF and LEAN

As the Effective Altruism community has grown, efforts have emerged to promote and support the growth of EA groups in universities and cities around the world. Presently there are three organisations supporting EA groups on a large scale. This article outlines the background of each organisation, and clarifies the functional... Read More

High Time For Drug Policy Reform. Part 3/4: Policy Suggestions, Tractability and Neglectedess

This is the third of four posts on DPR. In this part I look at what a better approach to drug policy might be and then discuss how neglected and tractable this problem is as cause area of EAs to work on. Links to the articles in this series: Part 1  (1,800... Read More

High Time For Drug Policy Reform. Part 2/4: Six Ways It Could Do Good And Anticipating The Objections

This is the second in a series of four posts on drug policy reform ('DPR'). In this post section 2 discusses six different ways DPR may do good. Section 3 anticipates several objections one might make against DPR if you doubted it would have a positive impact. I note these... Read More

Introducing Improving autonomy

Following on from an attempt to define a measure for autonomy , I've decided to try and build a community around exploring the idea of improving autonomy for humanity. I've created a main site  and a subreddit  for discussions.   My plans are to write more on the ideas of... Read More

High Time For Drug Policy Reform. Part 1/4: Introduction and Cause Summary

In the last 4 months, I’ve come to believe drug policy reform, changing the laws on currently illegal psychoactive substances, may offer a substantial, if not the most substantial, opportunity to increase the happiness of humans alive today. I consider this result very surprising. I’ve been researching how best to... Read More

Introducing Enthea

In advance of EA Global San Francisco, I'm launching Enthea , a research project assessing the humanitarian impact of psilocybin.  All that's on the site so far is a landing page with a statement of intent, which I've cross-posted below. Over the next few months, I'll be updating the site... Read More

Effective Altruism as a Market in Moral Goods – Introduction

This is post 1 of a 5-part series, where I tentatively apply the market and network concepts in the table below (links to definitions/examples) to hopefully gain a better applied understanding of how the EA community operates. I welcome your feedback in the comments section throughout.   1) Introduction 2)... Read More

Medical research: cancer is hugely overfunded; here's what to choose instead

  Note: the below was posted to my blog ; I expect formatting etc will be rendered better there. Also some important appendices and footnotes are available there, but not here. Apologies to international readers for the UK slant on this article, although I suspect that a similar story would apply... Read More

View more: Next